Which companies overlap with Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.'s portfolio?

Top competitors by shared drug class: Aduro Biotech, Inc., Aeras, Aga Khan University, Aimei Vacin BioPharm (Zhejiang) Co., Ltd., Alba Maria Ropero.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/laboratorios-de-biologicos-y-reactivos-de-m-xico-s-a-de-c-v.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. pipeline: 1 marketed, 0 filed, 4 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 4 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
serum antiscorpion	serum antiscorpion	marketed	Antivenom (polyclonal antiserum)	Scorpion venom toxins (multiple epitopes)	Toxicology / Emergency Medicine
Anti-scorpion venom serum Alacramyn	Anti-scorpion venom serum Alacramyn	phase 3	Antivenom serum		Toxicology / Emergency Medicine
Anti-scorpion venom serum Birmex	Anti-scorpion venom serum Birmex	phase 3	Antivenom (polyclonal antiserum)	Scorpion venom toxins (multiple components including neurotoxins)	Toxicology / Emergency Medicine
Trivalent OPV Birmex	Trivalent OPV Birmex	phase 3	vaccine		Infectious Diseases
Trivalent OPV Sanofi Pasteur	Trivalent OPV Sanofi Pasteur	phase 3	vaccine		Infectious Disease

Therapeutic area mix

Toxicology / Emergency Medicine · 3
Infectious Disease · 1
Infectious Diseases · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Aduro Biotech, Inc. · 1 shared drug class
Aeras · 1 shared drug class
Aga Khan University · 1 shared drug class
Aimei Vacin BioPharm (Zhejiang) Co., Ltd. · 1 shared drug class
Alba Maria Ropero · 1 shared drug class
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · 1 shared drug class
Asoc. Prof. Erdoğan Selçuk Şeber · 1 shared drug class
ANRS, Emerging Infectious Diseases · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.:

Cite this brief

Drug Landscape (2026). Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/laboratorios-de-biologicos-y-reactivos-de-m-xico-s-a-de-c-v. Accessed 2026-05-18.